Strategic Expansion Global growth through recent office openings in Cambridge and Greater Boston, North America, plus a strategic merger with Caidya signals increased footprint and capabilities to support larger, geographically diverse clinical programs.

Full Service CRO As a global, full-service CRO offering end-to-end clinical development from First-in-Human to post-marketing, Simbec-Orion can position itself as a comprehensive partner for sponsors seeking a single, integrated solution to streamline timelines and reduce vendor management complexity.

Therapeutic Expertise Specialist strengths in clinical pharmacology, oncology, and rare diseases create targeted upsell opportunities with sponsors focusing on these areas, where deep domain knowledge can differentiate service delivery and accelerate trial design and execution.

Data Sciences Growth New leadership in data sciences and partnerships with digital/AI-oriented firms position Simbec-Orion to offer advanced analytics, modelling, and real-world data capabilities as premium services to improve trial efficiency and decision-making.

Mid-Scale Growth Mid-size sponsor focus with scalable, tailor-made delivery aligns with Simbec-Orion’s revenue tier and service model, suggesting opportunities to pursue mid-market biotechs and specialty firms seeking flexible, high-quality CRO partnerships with personal attention.